The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Astragalus Injection Market Research Report 2024
Synopsis
Global Astragalus Injection market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Astragalus Injection market research.
Key manufacturers engaged in the Astragalus Injection industry include HeiLongJiang ZBD Pharmaceutical Co., Ltd., China Shineway Pharmaceutical Group Limited, Shanghai Pharmaceuticals Holding Co., Ltd., Shanghai Fuda Pharmaceutical Co., Ltd., Dali Pharmaceutical Co., Ltd., Beijing Langzhi Enterprise Management Co., Ltd., Jiangsu Jiuxu Pharmaceutical Co., Ltd., Harbin Shengtai Biopharmaceutical Co., Ltd. and China Resources Double-Crane Pharmaceutical Co.,Ltd., etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Astragalus Injection were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Astragalus Injection market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Astragalus Injection market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
HeiLongJiang ZBD Pharmaceutical Co., Ltd.
China Shineway Pharmaceutical Group Limited
Shanghai Pharmaceuticals Holding Co., Ltd.
Shanghai Fuda Pharmaceutical Co., Ltd.
Dali Pharmaceutical Co., Ltd.
Beijing Langzhi Enterprise Management Co., Ltd.
Jiangsu Jiuxu Pharmaceutical Co., Ltd.
Harbin Shengtai Biopharmaceutical Co., Ltd.
China Resources Double-Crane Pharmaceutical Co.,Ltd.
Segment by Type
10ml
2ml
Segment by Application
Hospital
Clinic
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Astragalus Injection report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Global Astragalus Injection market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Astragalus Injection market research.
Key manufacturers engaged in the Astragalus Injection industry include HeiLongJiang ZBD Pharmaceutical Co., Ltd., China Shineway Pharmaceutical Group Limited, Shanghai Pharmaceuticals Holding Co., Ltd., Shanghai Fuda Pharmaceutical Co., Ltd., Dali Pharmaceutical Co., Ltd., Beijing Langzhi Enterprise Management Co., Ltd., Jiangsu Jiuxu Pharmaceutical Co., Ltd., Harbin Shengtai Biopharmaceutical Co., Ltd. and China Resources Double-Crane Pharmaceutical Co.,Ltd., etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Astragalus Injection were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Astragalus Injection market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Astragalus Injection market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
HeiLongJiang ZBD Pharmaceutical Co., Ltd.
China Shineway Pharmaceutical Group Limited
Shanghai Pharmaceuticals Holding Co., Ltd.
Shanghai Fuda Pharmaceutical Co., Ltd.
Dali Pharmaceutical Co., Ltd.
Beijing Langzhi Enterprise Management Co., Ltd.
Jiangsu Jiuxu Pharmaceutical Co., Ltd.
Harbin Shengtai Biopharmaceutical Co., Ltd.
China Resources Double-Crane Pharmaceutical Co.,Ltd.
Segment by Type
10ml
2ml
Segment by Application
Hospital
Clinic
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Astragalus Injection report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index1 Astragalus Injection Market Overview
1.1 Product Overview and Scope of Astragalus Injection
1.2 Astragalus Injection Segment by Type
1.2.1 Global Astragalus Injection Market Value Comparison by Type (2023-2029)
1.2.2 10ml
1.2.3 2ml
1.3 Astragalus Injection Segment by Application
1.3.1 Global Astragalus Injection Market Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Astragalus Injection Market Size Estimates and Forecasts
1.4.1 Global Astragalus Injection Revenue 2018-2029
1.4.2 Global Astragalus Injection Sales 2018-2029
1.4.3 Global Astragalus Injection Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Astragalus Injection Market Competition by Manufacturers
2.1 Global Astragalus Injection Sales Market Share by Manufacturers (2018-2023)
2.2 Global Astragalus Injection Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Astragalus Injection Average Price by Manufacturers (2018-2023)
2.4 Global Astragalus Injection Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Astragalus Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Astragalus Injection, Product Type & Application
2.7 Astragalus Injection Market Competitive Situation and Trends
2.7.1 Astragalus Injection Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Astragalus Injection Players Market Share by Revenue
2.7.3 Global Astragalus Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Astragalus Injection Retrospective Market Scenario by Region
3.1 Global Astragalus Injection Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Astragalus Injection Global Astragalus Injection Sales by Region: 2018-2029
3.2.1 Global Astragalus Injection Sales by Region: 2018-2023
3.2.2 Global Astragalus Injection Sales by Region: 2024-2029
3.3 Global Astragalus Injection Global Astragalus Injection Revenue by Region: 2018-2029
3.3.1 Global Astragalus Injection Revenue by Region: 2018-2023
3.3.2 Global Astragalus Injection Revenue by Region: 2024-2029
3.4 North America Astragalus Injection Market Facts & Figures by Country
3.4.1 North America Astragalus Injection Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Astragalus Injection Sales by Country (2018-2029)
3.4.3 North America Astragalus Injection Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Astragalus Injection Market Facts & Figures by Country
3.5.1 Europe Astragalus Injection Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Astragalus Injection Sales by Country (2018-2029)
3.5.3 Europe Astragalus Injection Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Astragalus Injection Market Facts & Figures by Country
3.6.1 Asia Pacific Astragalus Injection Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Astragalus Injection Sales by Country (2018-2029)
3.6.3 Asia Pacific Astragalus Injection Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Astragalus Injection Market Facts & Figures by Country
3.7.1 Latin America Astragalus Injection Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Astragalus Injection Sales by Country (2018-2029)
3.7.3 Latin America Astragalus Injection Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Astragalus Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Astragalus Injection Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Astragalus Injection Sales by Country (2018-2029)
3.8.3 Middle East and Africa Astragalus Injection Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Astragalus Injection Sales by Type (2018-2029)
4.1.1 Global Astragalus Injection Sales by Type (2018-2023)
4.1.2 Global Astragalus Injection Sales by Type (2024-2029)
4.1.3 Global Astragalus Injection Sales Market Share by Type (2018-2029)
4.2 Global Astragalus Injection Revenue by Type (2018-2029)
4.2.1 Global Astragalus Injection Revenue by Type (2018-2023)
4.2.2 Global Astragalus Injection Revenue by Type (2024-2029)
4.2.3 Global Astragalus Injection Revenue Market Share by Type (2018-2029)
4.3 Global Astragalus Injection Price by Type (2018-2029)
5 Segment by Application
5.1 Global Astragalus Injection Sales by Application (2018-2029)
5.1.1 Global Astragalus Injection Sales by Application (2018-2023)
5.1.2 Global Astragalus Injection Sales by Application (2024-2029)
5.1.3 Global Astragalus Injection Sales Market Share by Application (2018-2029)
5.2 Global Astragalus Injection Revenue by Application (2018-2029)
5.2.1 Global Astragalus Injection Revenue by Application (2018-2023)
5.2.2 Global Astragalus Injection Revenue by Application (2024-2029)
5.2.3 Global Astragalus Injection Revenue Market Share by Application (2018-2029)
5.3 Global Astragalus Injection Price by Application (2018-2029)
6 Key Companies Profiled
6.1 HeiLongJiang ZBD Pharmaceutical Co., Ltd.
6.1.1 HeiLongJiang ZBD Pharmaceutical Co., Ltd. Corporation Information
6.1.2 HeiLongJiang ZBD Pharmaceutical Co., Ltd. Description and Business Overview
6.1.3 HeiLongJiang ZBD Pharmaceutical Co., Ltd. Astragalus Injection Sales, Revenue and Gross Margin (2018-2023)
6.1.4 HeiLongJiang ZBD Pharmaceutical Co., Ltd. Astragalus Injection Product Portfolio
6.1.5 HeiLongJiang ZBD Pharmaceutical Co., Ltd. Recent Developments/Updates
6.2 China Shineway Pharmaceutical Group Limited
6.2.1 China Shineway Pharmaceutical Group Limited Corporation Information
6.2.2 China Shineway Pharmaceutical Group Limited Description and Business Overview
6.2.3 China Shineway Pharmaceutical Group Limited Astragalus Injection Sales, Revenue and Gross Margin (2018-2023)
6.2.4 China Shineway Pharmaceutical Group Limited Astragalus Injection Product Portfolio
6.2.5 China Shineway Pharmaceutical Group Limited Recent Developments/Updates
6.3 Shanghai Pharmaceuticals Holding Co., Ltd.
6.3.1 Shanghai Pharmaceuticals Holding Co., Ltd. Corporation Information
6.3.2 Shanghai Pharmaceuticals Holding Co., Ltd. Description and Business Overview
6.3.3 Shanghai Pharmaceuticals Holding Co., Ltd. Astragalus Injection Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Shanghai Pharmaceuticals Holding Co., Ltd. Astragalus Injection Product Portfolio
6.3.5 Shanghai Pharmaceuticals Holding Co., Ltd. Recent Developments/Updates
6.4 Shanghai Fuda Pharmaceutical Co., Ltd.
6.4.1 Shanghai Fuda Pharmaceutical Co., Ltd. Corporation Information
6.4.2 Shanghai Fuda Pharmaceutical Co., Ltd. Description and Business Overview
6.4.3 Shanghai Fuda Pharmaceutical Co., Ltd. Astragalus Injection Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Shanghai Fuda Pharmaceutical Co., Ltd. Astragalus Injection Product Portfolio
6.4.5 Shanghai Fuda Pharmaceutical Co., Ltd. Recent Developments/Updates
6.5 Dali Pharmaceutical Co., Ltd.
6.5.1 Dali Pharmaceutical Co., Ltd. Corporation Information
6.5.2 Dali Pharmaceutical Co., Ltd. Description and Business Overview
6.5.3 Dali Pharmaceutical Co., Ltd. Astragalus Injection Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Dali Pharmaceutical Co., Ltd. Astragalus Injection Product Portfolio
6.5.5 Dali Pharmaceutical Co., Ltd. Recent Developments/Updates
6.6 Beijing Langzhi Enterprise Management Co., Ltd.
6.6.1 Beijing Langzhi Enterprise Management Co., Ltd. Corporation Information
6.6.2 Beijing Langzhi Enterprise Management Co., Ltd. Description and Business Overview
6.6.3 Beijing Langzhi Enterprise Management Co., Ltd. Astragalus Injection Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Beijing Langzhi Enterprise Management Co., Ltd. Astragalus Injection Product Portfolio
6.6.5 Beijing Langzhi Enterprise Management Co., Ltd. Recent Developments/Updates
6.7 Jiangsu Jiuxu Pharmaceutical Co., Ltd.
6.6.1 Jiangsu Jiuxu Pharmaceutical Co., Ltd. Corporation Information
6.6.2 Jiangsu Jiuxu Pharmaceutical Co., Ltd. Description and Business Overview
6.6.3 Jiangsu Jiuxu Pharmaceutical Co., Ltd. Astragalus Injection Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Jiangsu Jiuxu Pharmaceutical Co., Ltd. Astragalus Injection Product Portfolio
6.7.5 Jiangsu Jiuxu Pharmaceutical Co., Ltd. Recent Developments/Updates
6.8 Harbin Shengtai Biopharmaceutical Co., Ltd.
6.8.1 Harbin Shengtai Biopharmaceutical Co., Ltd. Corporation Information
6.8.2 Harbin Shengtai Biopharmaceutical Co., Ltd. Description and Business Overview
6.8.3 Harbin Shengtai Biopharmaceutical Co., Ltd. Astragalus Injection Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Harbin Shengtai Biopharmaceutical Co., Ltd. Astragalus Injection Product Portfolio
6.8.5 Harbin Shengtai Biopharmaceutical Co., Ltd. Recent Developments/Updates
6.9 China Resources Double-Crane Pharmaceutical Co.,Ltd.
6.9.1 China Resources Double-Crane Pharmaceutical Co.,Ltd. Corporation Information
6.9.2 China Resources Double-Crane Pharmaceutical Co.,Ltd. Description and Business Overview
6.9.3 China Resources Double-Crane Pharmaceutical Co.,Ltd. Astragalus Injection Sales, Revenue and Gross Margin (2018-2023)
6.9.4 China Resources Double-Crane Pharmaceutical Co.,Ltd. Astragalus Injection Product Portfolio
6.9.5 China Resources Double-Crane Pharmaceutical Co.,Ltd. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Astragalus Injection Industry Chain Analysis
7.2 Astragalus Injection Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Astragalus Injection Production Mode & Process
7.4 Astragalus Injection Sales and Marketing
7.4.1 Astragalus Injection Sales Channels
7.4.2 Astragalus Injection Distributors
7.5 Astragalus Injection Customers
8 Astragalus Injection Market Dynamics
8.1 Astragalus Injection Industry Trends
8.2 Astragalus Injection Market Drivers
8.3 Astragalus Injection Market Challenges
8.4 Astragalus Injection Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
